{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:25:15Z","timestamp":1782854715581,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jsbmb.2022.106117","type":"journal-article","created":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T11:22:15Z","timestamp":1651317735000},"page":"106117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia"],"prefix":"10.1016","volume":"221","author":[{"given":"Haoxin","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2022.106117_bib1","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","article-title":"How common is prostatitis? A national survey of physician visits","volume":"159","author":"Collins","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1464-410X.2000.00836.x","article-title":"Epidemiology of prostatitis in Finnish men: a population\u2010based cross\u2010sectional study","volume":"86","author":"Mehik","year":"2000","journal-title":"BJU Int."},{"key":"10.1016\/j.jsbmb.2022.106117_bib3","first-page":"189","article-title":"Prevalence of prostatitis-like symptoms in Singapore: a population-based study","volume":"43","author":"Tan","year":"2002","journal-title":"Singap. Med. J."},{"key":"10.1016\/j.jsbmb.2022.106117_bib4","first-page":"279","article-title":"Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia","volume":"43","author":"Aaron","year":"2016","journal-title":"J. Urol. Clin."},{"key":"10.1016\/j.jsbmb.2022.106117_bib5","first-page":"1","article-title":"The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"7","author":"Lee","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0047-6374(95)01593-O","article-title":"Development, Ageing and prostate: age-related changes in androgen receptors of epithelial cells from benign hypertrophic glands compared with cancer","volume":"82","author":"Sanchez-Visconti","year":"1995","journal-title":"Mech. Ageing"},{"key":"10.1016\/j.jsbmb.2022.106117_bib7","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.ajpath.2013.02.028","article-title":"Androgen receptor roles in the development of benign prostate hyperplasia","volume":"182","author":"Izumi","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajur.2019.10.003","article-title":"The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review","volume":"7","author":"Vickman","year":"2020","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/er.2016-1067","article-title":"Dihydrotestosterone: biochemistry, physiology, and clinical implications of elevated blood levels","volume":"38","author":"Swerdloff","year":"2017","journal-title":"J. Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2022.106117_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12020-018-1593-5","article-title":"Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?","volume":"61","author":"Giatti","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2022.106117_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.beem.2008.01.001","article-title":"Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate","volume":"22","author":"Barbier","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106117_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jsbmb.2022.106117_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tem.2003.10.005","article-title":"Metabolism, Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans","volume":"14","author":"B\u00e9langer","year":"2003","journal-title":"Trends Endocrinol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsbmb.2008.03.016","article-title":"Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling","volume":"109","author":"Chouinard","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib15","doi-asserted-by":"crossref","first-page":"33466","DOI":"10.1074\/jbc.M703370200","article-title":"UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells","volume":"282","author":"Chouinard","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2022.106117_bib16","doi-asserted-by":"crossref","first-page":"E428","DOI":"10.1210\/jc.2011-2064","article-title":"Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression","volume":"97","author":"P\u00e2quet","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2022.106117_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia\u2013what do we know?","volume":"127","author":"Devlin","year":"2021","journal-title":"BJU Int."},{"key":"10.1016\/j.jsbmb.2022.106117_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1254\/jjp.79.447","article-title":"Naftopidil, a novel \u03b11-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human \u03b11-adrenoceptors","volume":"79","author":"Takei","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1185\/03007995.2013.861813","article-title":"Naftopidil for the treatment of benign prostate hyperplasia: a systematic review","volume":"30","author":"Castiglione","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jsbmb.2022.106117_bib20","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.3390\/ijms21155339","article-title":"Drug repositioning of the \u03b11-adrenergic receptor antagonist naftopidil: a potential new anti-cancer drug?","volume":"21","author":"Florent","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jsbmb.2022.106117_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejphar.2016.09.009","article-title":"Pharmaceutical evaluation of naftopidil enantiomers: rat functional assays in vitro and estrogen\/androgen induced rat benign prostatic hyperplasia model in vivo","volume":"791","author":"Huang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/jphp.12281","article-title":"Identification of human cytochrome P450 isozymes involved in the metabolism of naftopidil enantiomers in vitro","volume":"66","author":"Zhu","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jpba.2016.09.038","article-title":"Poor and enantioselective bioavailability of naftopidil enantiomers is due to extensive and stereoselective metabolism in rat liver","volume":"132","author":"Liu","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jsbmb.2022.106117_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3389\/fphar.2017.00984","article-title":"Human UDP-glucuronosyltransferase 2B4 and 2B7 are responsible for naftopidil glucuronidation in vitro","volume":"8","author":"Liu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pharmthera.2004.10.013","article-title":"UDP-glucuronosyltransferases and clinical drug-drug interactions","volume":"106","author":"Kiang","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2022.106117_bib26","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/jo062674j","article-title":"Zinc (II) perchlorate hexahydrate catalyzed opening of epoxide ring by amines: applications to synthesis of (RS)\/(R)-propranolols and (RS)\/(R)\/(S)-naftopidils","volume":"72","author":"Shivani","year":"2007","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jsbmb.2022.106117_bib27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2116\/analsci.29.455","article-title":"Spectrophotometric method for the assay of steroid 5\u03b1-reductase activity of rat liver and prostate microsomes","volume":"29","author":"Iwai","year":"2013","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jsbmb.2022.106117_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/jpet.115.226118","article-title":"Regulation of human UGT2B15 and UGT2B17 by miR-376c in prostate cancer cell lines","volume":"354","author":"Wijayakumara","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2022.106117_bib29","first-page":"291","article-title":"A rapid and simple ultraperformance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS\/MS) method for the detection of glucuronic acid-conjugated steroid metabolites","volume":"25","author":"Rong","year":"2016","journal-title":"J.Chin. Pharm. Sci."},{"key":"10.1016\/j.jsbmb.2022.106117_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jsbmb.2014.05.009","article-title":"Multiple roles for UDP-glucuronosyltransferase (UGT) 2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution","volume":"145","author":"Gauthier-Landry","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2022.106117_bib31","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1158\/0008-5472.CAN-13-1462","article-title":"Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications","volume":"73","author":"Grosse","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2022.106117_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phrs.2016.02.021","article-title":"New insights into the androgen biotransformation in prostate cancer: a regulatory network among androgen, androgen receptors and UGTs","volume":"106","author":"Qin","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jsbmb.2022.106117_bib33","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.18632\/oncotarget.12277","article-title":"Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?","volume":"8","author":"Sundararaghavan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jsbmb.2022.106117_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","article-title":"The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence","volume":"7","author":"Mackenzie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jsbmb.2022.106117_bib35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/bj20011594","article-title":"Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones","volume":"365","author":"Girard","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.jsbmb.2022.106117_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/toxsci\/kfx072","article-title":"Uridine diphosphate-glucuronosyltransferase (UGT) 2B subfamily interspecies differences in carnivores","volume":"158","author":"Kondo","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jsbmb.2022.106117_bib37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2174\/1389200219666180307122945","article-title":"Regulation of mammalian UDP-glucuronosyltransferases","volume":"19","author":"Wang","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jsbmb.2022.106117_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/pros.20749","article-title":"Androgen receptor mediates the expression of UDP\u2010glucuronosyltransferase 2 B15 and B17 genes","volume":"68","author":"Bao","year":"2008","journal-title":"Prostate"}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076022000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:09:51Z","timestamp":1760746191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076022000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":38,"alternative-id":["S0960076022000681"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106117","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2022.106117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106117"}}